Perspective Therapeutics, Inc.

CATX · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$26$6-$18-$40
Dep. & Amort.$1$1$1$1
Deferred Tax$0-$8$0-$2
Stock-Based Comp.$2$5$2$2
Change in WC$7-$1-$5-$11
Other Non-Cash-$1-$23-$1$24
Operating Cash Flow-$16-$14-$22-$27
Investing Activities
PP&E Inv.-$2-$5-$5-$15
Net Acquisitions$0$0$0$0
Inv. Purchases-$32-$67-$23-$165
Inv. Sales/Matur.$48$72$22$41
Other Inv. Act.-$0$5-$0$0
Investing Cash Flow$14$4-$6-$139
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$10-$13
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$12
Financing Cash Flow$0$0$10$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$16-$17-$165
Supplemental Information
Beg. Cash$29$44$62$226
End Cash$27$29$44$62
Free Cash Flow-$18-$19-$26-$41